Cochrane Evidence Synthesis and Methods ►

Colchicine for the secondary prevention of cardiovascular events

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the benefits and harms of low-dose colchicine in the prevention of cardiovascular events in adults with a history of stable CVD or following myocardial infarction or stroke.

This is a protocol.

Published:

29 August 2023

Authors:

Ebrahimi F, Hirt J, Schönenberger C, Ewald H, Briel M, Janiaud P, Hemkens LG

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Ebrahimi F, Hirt J, Schönenberger C, Ewald H, Briel M, Janiaud P, Hemkens LG. Colchicine for the secondary prevention of cardiovascular events (Protocol). Cochrane Database of Systematic Reviews 2023, Issue 8. Art. No.: CD014808. DOI: 10.1002/14651858.CD014808.